Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

51.63
Delayed Data
As of 4:02pm ET
 -1.57 / -2.95%
Today’s Change
49.87
Today|||52-Week Range
66.58
-21.34%
Year-to-Date
Why EpiPen, Why Now: Analysts Explain the Timing of Mylan's Trouble
4:52pm / TheStreet.com - Paid Partner Content
Swiss Generics Manufacturer Has Strong 1st Half of Year
Aug 22 / GuruFocus News - Paid Partner Content
Why Momenta Pharmaceuticals Shares Made a Late-Day Jump Higher
4:50pm / MotleyFool.com - Paid Partner Content
Pfizer's (PFE) Pain Drug Troxyca ER Receives FDA Approval
Aug 22 / Zacks.com - Paid Partner Content
Mylan Falls After Being Called Out on Price Increases -- Should You Worry?
4:09pm / TheStreet.com - Paid Partner Content
Top Research Reports for August 19, 2016
Aug 19 / Zacks.com - Paid Partner Content
Teva Stock Drops After Patent Invalidated
3:55pm / TheStreet.com - Paid Partner Content
Teva Cinqaero Gets EU Nod for Severe Eosinophilic Asthma
Aug 19 / Zacks.com - Paid Partner Content
A Backlash Materializes Against Soaring EpiPen Prices
Aug 23 / TheStreet.com - Paid Partner Content
Allergan to Buy ForSight VISION5, Boost Glaucoma Pipeline
Aug 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close53.20
Today’s open53.53
Day’s range49.87 - 53.96
Volume16,140,806
Average volume (3 months)6,140,663
Market cap$54.0B
Dividend yield2.63%
Data as of 4:02pm ET, 08/24/2016

Growth & Valuation

Earnings growth (last year)-48.62%
Earnings growth (this year)-2.58%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)-3.22%
P/E ratio34.7
Price/Sales2.89
Price/Book1.82

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd-1.41-4.79%
OASMOasmia Pharmaceutica...-0.02-0.61%
VBLTVascular Biogenics L...-0.09-2.20%
DNAIProNAi Therapeutics ...-0.06-3.06%
Data as of 3:59pm ET, 08/24/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)$1.36
Annual revenue (last year)$19.6B
Annual profit (last year)$1.6B
Net profit margin8.09%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Erez Vigodman
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Tel Aviv

Forecasts

Partner Offers

Search for Jobs